What is the CHA2DS2-VASc (Congestive heart failure, Hypertension, Age ≥ 75 years, Diabetes, Stroke or transient ischemic attack, Vascular disease, Age 65-74 years, Sex category) score for a 72-year-old female with a history of Ethanol (ETOH) abuse?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The CHA2DS2-VASc score for a 72-year-old female with a history of ethanol abuse is 3 points, calculated by assigning 1 point for age 65-74 years and 2 points for female sex, as the history of ethanol abuse alone does not contribute to the CHA2DS2-VASc score. This scoring system is used to assess stroke risk in patients with atrial fibrillation and helps determine the need for anticoagulation therapy, as discussed in the 2023 ACC/AHA/ACCp/HRS guideline for the diagnosis and management of atrial fibrillation 1. A score of 3 indicates a moderate-high risk of stroke, with an annual stroke risk that can be estimated based on the most recent guidelines. For patients with this score, oral anticoagulation therapy is typically recommended unless contraindicated, as stated in the 2016 ESC guidelines for the management of atrial fibrillation 1. The patient's history of alcohol abuse should be considered when selecting anticoagulation, as it may affect liver function and medication compliance, highlighting the importance of regular monitoring of liver function and careful assessment of bleeding risk in managing this patient's anticoagulation needs.

Key considerations in managing anticoagulation for this patient include:

  • The choice of anticoagulant, considering the patient's history of ethanol abuse and its potential impact on liver function and medication adherence.
  • Regular monitoring of liver function to adjust anticoagulation therapy as needed.
  • Careful assessment of bleeding risk to balance the benefits of anticoagulation against the potential risks.
  • Patient education on the importance of adherence to anticoagulation therapy and regular follow-up appointments to monitor therapy effectiveness and adjust as necessary, based on guidelines such as those provided by the European Heart Journal 1 and the Journal of the American College of Cardiology 1.

From the Research

Calculating CHA2DS2-VASc Score

To calculate the CHA2DS2-VASc score for a 72-year-old female with a history of ethanol (ETOH) abuse, we need to consider the following factors:

  • Congestive heart failure: Not mentioned
  • Hypertension: Not mentioned
  • Age ≥ 75 years: No (score 0)
  • Diabetes: Not mentioned
  • Stroke or transient ischemic attack: Not mentioned
  • Vascular disease: Not mentioned (history of ETOH abuse is not directly considered in the CHA2DS2-VASc score)
  • Age 65-74 years: Yes (score 1)
  • Sex category: Female (score 1)

Scoring

Based on the available information, the CHA2DS2-VASc score for this patient would be:

  • Age 65-74 years: 1 point
  • Female sex: 1 point Total score: 2

Considerations

It is essential to note that the CHA2DS2-VASc score is used to assess the risk of stroke in patients with atrial fibrillation, and the score may not be directly applicable to patients with other conditions. However, the score can provide a general idea of the patient's risk factors for stroke 2, 3, 4, 5, 6.

Risk Factors

The patient's history of ETOH abuse may increase the risk of stroke, but it is not directly considered in the CHA2DS2-VASc score. Other risk factors, such as hypertension, diabetes, and vascular disease, are not mentioned and should be evaluated separately.

Anticoagulation Recommendations

According to the guidelines, patients with a CHA2DS2-VASc score of 2 or higher should receive anticoagulation therapy 4. However, the decision to initiate anticoagulation should be individualized based on the patient's overall risk profile and other medical conditions.

Related Questions

What anticoagulation therapy is recommended for patients with a CHA2DS2-VASc (Congestive heart failure, Hypertension, Age ≥ 75 years, Diabetes, Stroke or transient ischemic attack, Vascular disease, Age 65-74 years, Sex category) score of more than 2?
Can the CHADS(Vascular) VASc score be used in valvular atrial fibrillation?
What is the most appropriate treatment for a 45-year-old female with new onset Atrial Fibrillation (Afib) who converted to Normal Sinus Rhythm (NSR) after 48 hours, has a CHA2DS-VASc (Congestive heart failure, Hypertension, Age ≥ 75 years, Diabetes, Stroke or transient ischemic attack, Vascular disease, Age 65-74 years, Sex category) score of 1, and recently had Pneumonia (PNA) with sepsis?
What is the recommended anticoagulation therapy for a patient with paroxysmal atrial fibrillation (AF) and a CHA2DS2-VASc (Congestive heart failure, Hypertension, Age ≥ 75 years, Diabetes, Stroke or transient ischemic attack, Vascular disease, Age 65-74 years, Sex category) score of 2?
Can anticoagulation be started for a patient with a CHA2DS2-VASc (Cardiac failure, Hypertension, Age >= 75, Diabetes, Stroke/TIA/thromboembolism, Vascular disease, Age 65-74, Sex category) score of 2?
Are Testosign (testosterone) gelatin capsules liposomal?
What are the initial nursing interventions for patients with elevated liver enzymes?
What are the treatment options for hyperthyroidism with elevated free T3 (triiodothyronine) and free T4 (thyroxine) levels and a normal Thyroid-Stimulating Hormone (TSH) level?
If a fetal encephalocele is diagnosed on ultrasound, is the next best step a 3D (three-dimensional) imaging or a fetal MRI (Magnetic Resonance Imaging)?
What does excessive shaking after a cesarean section (c-section) indicate?
How to lower elevated liver enzymes?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.